UBS Group’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $307K | Buy |
|
|||||
|
2025
Q1 | $100K | Buy |
|
|||||
|
2024
Q4 | $110K | Buy |
|
|||||
|
2024
Q3 | $303 | Sell |
|
|||||
|
2024
Q2 | $36.7K | Sell |
|
|||||
|
2024
Q1 | $121K | Sell |
|
|||||
|
2023
Q4 | $104K | Buy |
|
|||||
|
2023
Q3 | $67K | Buy |
|
|||||
|
2023
Q2 | $85.4K | Buy |
|
|||||
|
2023
Q1 | $428 | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $43K | Sell |
|
|||||
|
2021
Q4 | $150K | Buy |
|
|||||
|
2021
Q3 | $115K | Buy |
|
|||||
|
2021
Q2 | $164K | Sell |
|
|||||
|
2021
Q1 | $201K | Buy |
|
|||||
|
2020
Q4 | $104K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $9K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $4K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $6K | Sell |
|
|||||
|
2018
Q1 | $17K | Buy |
|
|||||
|
2017
Q4 | $6K | Sell |
|
|||||
|
2017
Q3 | $6K | Buy |
|